Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 14, 2000, Pages 1543-1545

  Blass, Benjamin E ^a   Huang, C T ^a   Kawamoto, Richard M ^a   Li, Min ^a   Liu, Song ^a   Portlock, David E ^a   Rennells, William M ^a   Simmons, Melanie ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; IMIDAZOLE DERIVATIVE;

ARTICLE; CHEMICAL MODIFICATION; CONGESTIVE HEART FAILURE; DOG; DRUG INHIBITION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; NONHUMAN; REACTION ANALYSIS;

AMINES; ANIMALS; DOGS; ENZYME INHIBITORS; IMIDAZOLES; INDICATORS AND REAGENTS; KINETICS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; SARCOLEMMA;

EID: 0034679644     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00296-1     Document Type: Article

References (12)

1. The Heart Arteries and Veins; Hurst, J. W., Schlant, R. C., Rackley, C. E., Sonnenblick, E. H., Wenger, N. K., Eds.; McGraw Hill: New York, 1990.
2. American Heart Association statistics from 1996.
3. The Heart Arteries and Viens; Hurst, J. W., Schlant, R. C., Rackley, C. E., Sonnenblick, E. H., Wenger, N. K., Eds.; McGraw-Hill: New York, 1990.
4. Martindale: The Complete Drug Reference; Parfitt, K., Ed.; Pharmaceuticals: Taunton, 1999; 849.
5. Borchard, U.; Boesken, R.; Greeff, K. Arch. Int. Pharmacodyn. Ther. 1982, 256, 253. Fox, A. A. L.; Greeff, K. Biochem. Pharmacol. 1981, 30, 611. Peer, D.: Mayan, H.; Cohen, H.; Tal, D.M.; Karlish, S. J. D. J. Biol. Chem. 1992, 267, 1141.
6. Borchard, U.; Boesken, R.; Greeff, K. Arch. Int. Pharmacodyn. Ther. 1982, 256, 253. Fox, A. A. L.; Greeff, K. Biochem. Pharmacol. 1981, 30, 611. Peer, D.: Mayan, H.; Cohen, H.; Tal, D.M.; Karlish, S. J. D. J. Biol. Chem. 1992, 267, 1141.
7. Borchard, U.; Boesken, R.; Greeff, K. Arch. Int. Pharmacodyn. Ther. 1982, 256, 253. Fox, A. A. L.; Greeff, K. Biochem. Pharmacol. 1981, 30, 611. Peer, D.: Mayan, H.; Cohen, H.; Tal, D.M.; Karlish, S. J. D. J. Biol. Chem. 1992, 267, 1141.
8. Iddon B. Heterocycles. 23:1985;417.
9. For related chemistry see Bierer, D. E.; O'Connell, J. F.; Parquette, J. R.; Thompson, C. M.; Rapoport, H. J. Org. Chem. 1992, 57, 1390.
10. MacGregor, S. E.; Walker, J. M. Appl. Biochem. Biotech. 1994, 49, 135. Jones, L. R.; Maddock, S. W.; Besch, H. R. Jr. J. Biol. Chem. 1980, 255, 9971.
11. MacGregor, S. E.; Walker, J. M. Appl. Biochem. Biotech. 1994, 49, 135. Jones, L. R.; Maddock, S. W.; Besch, H. R. Jr. J. Biol. Chem. 1980, 255, 9971.
12. -1. Mass spectrum m/z (%): 278 (M+1, 100%).